MWNA
ARAV

Marshall Wace North America’s Aravive, Inc. Common Stock ARAV Stock Holding History

Marshall Wace North America’s Portfolio ARAV Stock Details ARAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-4,856
Closed -$495K – 1562
2017
Q2 		$495K Buy
+4,856
New +$522K ﹤0.01% 1093

Other funds holding ARAV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
AC
Ascend Capital Orinda, California $1.99B AUM 10.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Marshall Wace North America's ARAV Position: Q3 2017 in Review

Marshall Wace North America sold out of Aravive, Inc. Common Stock (ARAV) in Q3 2017, closing a stake of 4,856 shares — an estimated $495K sold.

Marshall Wace North America first reported a position in ARAV in Q2 2017 and held it in 1 quarter. The position peaked at $495K in Q2 2017. 105 funds tracked by Wall St. Rank hold ARAV as of Q3 2017.

  • Marshall Wace North America reported no remaining Aravive, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • Marshall Wace North America sold 4,856 Aravive, Inc. Common Stock shares in Q3 2017, an estimated $495K.
  • Marshall Wace North America first reported a position in Aravive, Inc. Common Stock in Q2 2017 and held it in 1 quarter.
  • Marshall Wace North America's Aravive, Inc. Common Stock position peaked at $495K in Q2 2017.
  • 105 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q3 2017.

Based on Marshall Wace North America's 13F filing for Q3 2017, filed 13 Nov 2017.